The CPhI Women in Leadership forum seeks to address issues head-on and provide constructive dialogue where experts in this industry share experiences and strategies helpful in establishing equality for everyone and unleashing untapped potential in the pharmaceuticals industry.
With the theme Empowering Women to Thrive, the CPhI North America’s forum is set to feature executives in the pharmaceuticals industry who will discuss the vitality and importance of women leaders and progression within the pharmaceutical and speciality chemicals markets, as well as challenges women still face.
There will be a full schedule of proceedings, including a keynote address by Lynn Taylor, head of corporate and government relations in US and head of healthcare global government and public affairs for Merck KGaA, Tina Garyantes from Chromocell, Hugh Welsh from DSM, and Mike Kosko from Pfizer.
“It’s pretty well understood that when you’re in the majority culture—it could be by gender, by race, by national origin—you’re completely blind to your privilege. And I was blind to the privilege that I enjoyed until I built up a relationship with those who are part of the minority culture in the company who could help enlighten me,” said High Welsh, DSM.
The CPhI Women in Leadership forum seeks to address issues head-on and provide constructive dialogue where experts in this industry share experiences and strategies helpful in establishing equality for everyone and unleashing untapped potential in the pharmaceuticals industry.
With the theme Empowering Women to Thrive, the CPhI North America’s forum is set to feature executives in the pharmaceuticals industry who will discuss the vitality and importance of women leaders and progression within the pharmaceutical and speciality chemicals markets, as well as challenges women still face.
There will be a full schedule of proceedings, including a keynote address by Lynn Taylor, head of corporate and government relations in US and head of healthcare global government and public affairs for Merck KGaA, Tina Garyantes from Chromocell, Hugh Welsh from DSM, and Mike Kosko from Pfizer.
“It’s pretty well understood that when you’re in the majority culture—it could be by gender, by race, by national origin—you’re completely blind to your privilege. And I was blind to the privilege that I enjoyed until I built up a relationship with those who are part of the minority culture in the company who could help enlighten me,” said High Welsh, DSM.
No comments:
Post a Comment